What is this about?
Artificial Intelligence (AI) can be used to fundamentally rethink how we solve the world’s problems.
AI has the potential to greatly improve things like education, poverty and security and especially healthcare. AI machines can do some very beneficial things already today that humans will simply never be able to.
The world’s leading drug companies are turning to AI to improve the trial-and-error business of discovering new drugs.
Pharmaceutical giants like GSK, Merck & Co, Johnson & Johnson and Sanofi are exploring the potential of AI to help streamline the drug discovery process.
The aim is to harness modern supercomputers and machine learning systems to predict how molecules will behave and how likely they are to make a useful drug, thereby saving time and money on unnecessary tests.
Many large pharma companies are starting to realize the potential of this approach and how it can help improve efficiencies.
Why is that a good thing?
To date, people with severe diseases cannot expect that a treatment for their disease will be discovered, researched and put on the market within their lifetime since this process generally takes decades.
Implementing AI in drug research’s main goal is to reduce the time it takes from identifying a target for disease intervention to finding a molecule that acts against it from an average 5.5 years today to just one year in future.
The AI system delivers drug candidates in roughly one-quarter of the time and at one-quarter of the cost of traditional approaches.
This might give people who are already suffering from severe diseases a hope for a cure, not only for future generations but also for people who are living today.
From an investor's standpoint, it can be certainly expected that big pharma stocks are looking forward to a big future of exploding revenue and earnings. A good time to consider adding big pharma to one's portfolio.
Did you find this interesting? Then feel free to check out my other articles and follow my blog.
For further information:
https://steemit.com/investing/@meisi51/top-3-artificial-intelligence-stocks-to-invest-in
